Stock 000403 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Pacific Shuanglin Bio-pharmacy Co., LTD

Equities

000403

CNE000000F14

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
27.9 CNY +0.36% Intraday chart for Pacific Shuanglin Bio-pharmacy Co., LTD +5.92% +2.42%
May. 27 Morgan Stanley Starts Pacific Shuanglin Bio-pharmacy at Overweight With 37 Yuan Price Target MT
May. 23 Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin MT

Business Summary

Pacific Shuanglin Bio pharmacy Co Ltd, formerly Southern Shuanglin Bio-pharmacy Co Ltd, formerly Zhenxing Biopharmaceutical & Chemical Co., Ltd., is a China-based company mainly engaged in the research, development, production and sales of blood products. The Company's main products are human albumin, intravenous immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin and rabies immunoglobulin. The Company mainly operates its business in the domestic market.

Number of employees: 2,426

Sales per Business

CNY in Million2022Weight2023Weight Delta
Blood
99.8 %
2,396 99.6 % 2,324 99.8 % -2.97%
Others
0.1 %
10 0.4 % 3 0.1 % -65.97%
Matrix Body
0.0 %
- - 1 0.0 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.4 %
2,292 95.3 % 2,291 98.4 % -0.04%
Abroad
1.6 %
113 4.7 % 37 1.6 % -66.90%

Managers

Managers TitleAgeSince
Ye Hong Wang DFI
 Director of Finance/CFO 33 21-03-25
Xiao Ying Huang BRD
 Director/Board Member 50 23-10-24
Yu Lin Zhao SEC
 Corporate Secretary 37 19-05-20

Members of the board

Members of the board TitleAgeSince
Jun Yin BRD
 Director/Board Member 69 23-10-24
Jin Gang Zhang BRD
 Director/Board Member 61 Dec. 10
Shao Lan Fu CHM
 Chairman 82 Dec. 10
Zuo Jun Dong BRD
 Director/Board Member 54 21-03-22
Xiao Ying Huang BRD
 Director/Board Member 50 23-10-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 736,580,544 406,262,225 ( 55.16 %) 3,537,253 ( 0.4802 %) 55.16 %

Shareholders

NameEquities%Valuation
Gongqingcheng Shengbang Yinghao Investment Partnership LP
24.05 %
153,752,812 24.05 % 564 M ¥
Shao Lan Fu
10.33 %
66,073,428 10.33 % 242 M ¥
KAISA GROUP HOLDINGS LTD.
5.351 %
34,217,201 5.351 % 126 M ¥
Ningbo Guojun Yuanhong Investment Management Co. Ltd.
3.411 %
21,808,400 3.411 % 80 M ¥
Fullgoal Fund Management Co., Ltd.
2.197 %
14,046,469 2.197 % 52 M ¥
HuaAn Fund Management Co., Ltd.
2.157 %
13,791,136 2.157 % 51 M ¥
Hengqin Guangjin Beautiful Fund Management Co., Ltd.
2.127 %
13,600,000 2.127 % 50 M ¥
Zhejiang United Investment Group
1.777 %
11,362,263 1.777 % 42 M ¥
Rongtong Fund Management Co., Ltd.
1.666 %
10,655,794 1.666 % 39 M ¥
Dajia Life Insurance Co. Ltd.
1.648 %
10,535,974 1.648 % 39 M ¥
NameEquities%Valuation
Shao Lan Fu
27.77 %
25,824,477 27.77 % 95 M ¥
Feng Yang
4.309 %
4,007,293 4.309 % 15 M ¥
Li Yang
4.309 %
4,007,293 4.309 % 15 M ¥
Zhejiang Minying Enterprise Joint Investment Co. Ltd.
4.072 %
3,787,421 4.072 % 14 M ¥
Jing Rui Zhang
2.873 %
2,671,531 2.873 % 10 M ¥
Ling Mou Huang
0.0448 %
41,686 0.0448 % 152 951 ¥
Hua Gang Yuan
0.0448 %
41,686 0.0448 % 152 951 ¥
Di Wu
0.0231 %
21,469 0.0231 % 78 772 ¥
Yu Lin Zhao
0.0161 %
14,964 0.0161 % 54 905 ¥
Zhi Bo Wang
0.0161 %
14,964 0.0161 % 54 905 ¥

Holdings

NameEquities%Valuation
PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD
0.15%
 988,501 0.15% 3,626,929 $

Company contact information

Pacific Shuanglin Bio-pharmacy Co., Ltd.

1, Xinfeng East Road Donghai Island, Dongjian Town

524072, Zhanjiang

+

http://www.slbiop.com
address Pacific Shuanglin Bio-pharmacy Co., LTD(000403)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Pacific Shuanglin Bio-pharmacy Co., LTD

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
27.9 CNY
Average target price
35.27 CNY
Spread / Average Target
+26.40%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD Stock Pacific Shuanglin Bio-pharmacy Co., LTD
+2.42% 2.79B
CSL LIMITED Stock CSL Limited
+6.42% 97.06B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+7.24% 41.54B
BIOGEN INC. Stock Biogen Inc.
-8.49% 33.89B
UCB Stock UCB
+83.27% 29.78B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-12.97% 15.63B
INCYTE CORPORATION Stock Incyte Corporation
-0.80% 13.66B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-12.22% 11.43B
ALTEOGEN INC. Stock ALTEOGEN Inc.
+173.60% 10.37B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.64% 9.14B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 000403 Stock
  4. Company Pacific Shuanglin Bio-pharmacy Co., LTD